J&J Settles Risperdal Marketing Claims From DOJ, States
Johnson & Johnson has settled claims brought by the U.S. Department of Justice and several states that it illegally marketed its antipsychotic drug Risperdal, as well as False Claims Act and...To view the full article, register now.
Already a subscriber? Click here to view full article